Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-26-012278
Filing Date
2026-02-10
Accepted
2026-02-10 06:01:54
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 19906
2 EXHIBIT 99.B tm265774d1_ex99-b.htm EX-99.B 58995
  Complete submission text file 0001104659-26-012278.txt   80595
Mailing Address ENTREMED, INC. 9640 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
He Wei-Wu (Filed by) CIK: 0001542073 (see all company filings)

Type: SCHEDULE 13D/A

Mailing Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025
Business Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025 86 10 6561 8789
CASI Pharmaceuticals, Inc. (Subject) CIK: 0001962738 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-94039 | Film No.: 26613345
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)